Galectin Therapeutics Inc (GALT.OQ)

GALT.OQ on NASDAQ Stock Exchange Capital Market

5.57USD
4:00pm EDT
Price Change (% chg)

$-0.16 (-2.79%)
Prev Close
$5.73
Open
$5.77
Day's High
$5.80
Day's Low
$5.51
Volume
51,334
Avg. Vol
140,957
52-wk High
$19.10
52-wk Low
$4.28

GALT.OQ

Chart for GALT.OQ

About

Galectin Therapeutics Inc., formerly Pro-Pharmaceuticals, Inc. is a development-stage company. The Company is engaged in drug development to create therapies for cancer and fibrotic disease. As of December 31, 2011, the Company has two compounds in development, one is to be used in cancer therapy and the other intended to be... (more)

Overall

Beta: 1.64
Market Cap (Mil.): $126.06
Shares Outstanding (Mil.): 22.00
Dividend: --
Yield (%): --

Financials

  GALT.OQ Industry Sector
P/E (TTM): -- 143.76 33.47
EPS (TTM): -0.83 -- --
ROI: -82.26 -2.42 17.39
ROE: -149.03 -7.11 18.25
Search Stocks

Competitors

  Price Change
Novartis AG (NOVN.VX) CHF88.45 -0.45
Merck & Co., Inc. (MRK.N) $60.31 +0.43
Roche Holding Ltd. (ROG.VX) CHF283.30 +2.50
Eli Lilly and Co (LLY.N) $66.59 +0.68
Momenta Pharmaceuticals, Inc. (MNTA.OQ) $11.60 +0.20

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks